Top Hedge Fund News, Member Posts, Hedge Fund Daily Indices and more!

3yrs ago Hedge Fund hedgeweek Views: 378

2nd Apr 2020 - 4:36pm

CloudMargin appoints Chief Commercial Officer

Submitted 02/04/2020 - 4:36pm

CloudMargin, creator of a collateral and margin management solution native to the cloud, has appointed David G White to the newly created role of Chief Commercial Officer. 

White has 14 years of capital markets experience in over-the-counter (OTC) derivatives markets and supporting technology.

 
Based in London and reporting to CloudMargin CEO Stuart Connolly, White is responsible for establishing and meeting targeted revenue objectives; overseeing the sales and marketing teams and ensuring cohesive strategies for those areas; enhancing the sales management processes, and working with partner firms to create a seamless platform for increased sales cohesion.
 
Connolly says: “I had a great working relationship with David at TriOptima and am delighted he has joined CloudMargin as our Chief Commercial Officer. This is an important new role for us as we continue to grow, and David will hit the ground running, thanks to his deep domain and technical expertise, understanding of our product, and strong working ties with our outstanding partners – such as AcadiaSoft – as well as many in our client universe. In these times of stress across our industry and the world, I know that David’s leadership, empathy, calm demeanour and compassionate professionalism will be a welcome addition to our team.”
 
White says: “I am hugely excited to join a fast-growing company in an important and evolving market.  With continued regulatory change, and a desire across the industry to drive new levels of efficiency, CloudMargin is well positioned to capitalise on the significant opportunity that exists and continue to carve out its place as a key market provider.  Having worked with Stuart previously, I know I am joining a company with a positive, energetic culture and thoroughly look forward to working with the talented team across the organisation.”
 
From 2016 to 2019, White served as Head of Sales for the triResolve business line of TriOptima, now a unit of CME Group. In that role, he was responsible for the global sales team, client acquisition and revenue growth of the firm’s counterparty exposure management service. For four years prior, he was Product Marketing Executive at TriOptima. Previously, White spent five years as a Consultant and Manager at DCG, The Derivatives Consulting Group, later known as Sapient Global Markets, specialising in OTC derivatives projects on behalf of Tier 1 investment bank clients.
 
Often tapped as a speaker on OTC derivatives for industry conferences, White earned a degree in Economics from Bristol University of the West of England.
 

Tags Moves & Appointments

Today's Hedge Fund Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.